Aula is an associate director in process development department at Recipharm Advanced Bio. In this role, she leads technology transfer from clients and collaborators, scale up efforts and process optimization to support manufacturing of nucleic acid drug product. Before joining ReciBio, Aula worked at Genevant Sciences as a scientist in process development team before moving to Providence Therapeutics where she worked on the development of COVID-19 vaccine. Aula earned her PhD in Chemistry at the University of Waterloo, ON, Canada in 2016.